N- and C-terminal Domains Direct Cell Type-specific Sorting of Chromogranin A to Secretory Granules*

Chromogranins are a family of regulated secretory proteins that are stored in secretory granules in endocrine and neuroendocrine cells and released in response to extracellular stimulation (regulated secre-tion). A conserved N-terminal disulfide bond is necessary for sorting of chromogranins in neuroendocrine PC12 cells. Surprisingly, this disulfide bond is not necessary for sorting of chromogranins in endocrine GH4C1 cells. To investigate the sorting mechanism in GH4C1 cells, we made several mutant forms removing highly conserved N- and C-terminal regions of bovine chromogranin A. Removing the conserved N-terminal disulfide bond and the conserved C-termi-nal dimerization and tetramerization domain did not affect the sorting of chromogranin A to the regulated secretory pathway. In contrast, removing the C-termi-nal 90 amino acids of chromogranin A caused rerout-ing to the constitutive secretory pathway and im-paired aggregation properties as compared with wild-type chromogranin A. Since this mutant was sorted to the regulated secretory pathway in PC12 cells, these results demonstrate that chromogranins contain independent N- and C-terminal sorting domains that function in a cell type-specific manner. Moreover, this is the first evidence that low pH/calcium-induced

Peptide hormones and neuropeptides are stored at high concentrations in secretory granules of endocrine and neuroendocrine cells. This storage is required for the proteolytic processing of prohormones and the subsequent rapid release of active peptides in response to extracellular stimulation (for review, see Refs. [1][2][3][4][5]. Secretory proteins that are not stored in secretory granules are secreted directly by the constitutive secretory pathway, originating in the trans-Golgi network (2) or the constitutive-like secretory pathway that originates from immature secretory granules (1). Thus, granule storage of secretory proteins appears to require two sorting steps (sorting for entry and sorting by retention; Ref. 3) that refine the final complement of stored proteins.
Several mechanisms have been proposed for sorting of secretory proteins into secretory granules. These sorting mechanisms include low pH and/or calcium-induced aggregation (6 -8), receptor-mediated transport of selected secretory proteins (8,9), and direct binding to specific lipid domains in granule membranes (10). Different sorting mechanisms appear to be responsible for sorting of different secretory proteins. Thus, pro-opiomelanocortin (POMC) 1 is sorted by binding to carboxypeptidase E and this sorting depends on an N-terminal disulfide bridge in POMC (9). Chromogranins contain a similar N-terminal disulfide bond that is both necessary and sufficient for sorting in PC12 cells (11)(12)(13)(14), although carboxypeptidase E does not appear to mediate this sorting (11,15). While chromogranins aggregate at low pH and in the presence of calcium, this aggregation is neither necessary nor sufficient for sorting in PC12 cells (12,16). In contrast, a narrowly defined aggregation domain is necessary for sorting of pro-atrial natriuretic factor to the regulated secretory pathway in AtT-20 cells (17). These findings suggest that individual secretory proteins contain protein-specific sorting signals that interact with different cellular sorting mechanisms.
It has long been assumed that regulated secretory proteins contain a single sorting domain that directs their sorting and storage in secretory granules (see, e.g., Ref. 18). However, we have recently found that the N-terminal disulfide bond that is necessary for sorting of chromogranin B in neuroendocrine PC12 cells (14) is not required for sorting in endocrine GH4C1 cells (11). This result suggests that, in endocrine cells, the signals and mechanisms used for sorting of regulated secretory proteins into secretory granules are different from those used in neuroendocrine cells. These endocrine-specific sorting signals remain unknown.
Chromogranin A (CgA) is a regulated secretory protein that is stored in secretory granules of both endocrine and neuroendocrine cells. To identify potential signals for sorting of CgA in endocrine cells, we prepared three mutants of bovine CgA. These mutants were designed to delete separately: 1) the Nterminal disulfide bond and dimerization domain (19), 2) the C-terminal domain involved in dimerization and tetramerization (20,21), and 3) a putative calcium-aggregation/condensation domain. The latter was based on our observation that an approximately 8-kDa peptide of CgA is necessary for calcium-induced aggregation at acidic pH (22).
We now report that the C-terminal domain of CgA is necessary for both sorting and for low pH/calcium-induced aggregation in GH4C1 cells. In contrast, it is shown that the C-terminal domain of CgA is not necessary for sorting to the regulated secretory pathway in PC12 cells. Together with previous results (11), these findings show that CgA contains two independent cell-specific sorting domains.

EXPERIMENTAL PROCEDURES
Materials-Laboratory reagents were purchased from Fisher or Sigma, unless otherwise indicated. Cell culture media and penicillin/ streptomycin were from Life Technologies, Inc. Fetal bovine and gelding equine serum were from HyClone Laboratories (Logan, UT). The expression plasmid pcDNA3 was purchased from Invitrogen (Carlsbad, CA), and restriction endonucleases were from Promega (Madison, WI). The [ 3 H]leucine and protein A-Sepharose were from Amersham Pharmacia Biotech. The site-directed mutagenesis kit, Transformer, was purchased from CLONTECH. Phospha-Light alkaline phosphatase assay kit was from Tropix/Perkin-Elmer (Bedford, MA), and rabbit antiplacental alkaline phosphatase antiserum was from Biomeda Corp. (Foster City, CA). The horseradish peroxidase-conjugated goat antirabbit IgG was purchased from Sigma or Roche Molecular Biochemicals. Phorbol didecanoate was from Calbiochem (La Jolla, CA), while the protease inhibitors phenylmethanesulfonyl fluoride (PMSF) and N ␣ -tosyl-L-lysine chloromethyl ketone were from Roche Molecular Biochemicals. Supersignal chemiluminescent reagents were from Pierce, polyvinylidene difluoride membrane was from Bio-Rad, and nitrocellulose membrane was obtained from Schleicher & Schuell. BioMax film was from Eastman Kodak Co. The antiserum to bovine CgA was kindly provided by Dr. David V. Cohn (University of Louisville, Louisville, KY).
Cloning and Mutagenesis-The expression plasmids for wild-type bovine CgA, CgA⌬CC (missing the disulfide bond), and secreted alkaline phosphatase (SEAP) were described previously (11,23). CgA341 and CgA387 were prepared from wild-type CgA by site-directed mutagenesis with primers from Genosys Biotechnologies Inc. (The Woodlands, TX). The selection primer (5Ј-ACTCTGGGGATCGATATGAC-CGACC-3Ј) changed the BstBI site of pcDNA3 to a unique ClaI site, whereas the mutagenesis primer for CgA341 (5Ј-GAGGAAGAGTAG-GATCCCGACCGC-3Ј) added a stop codon at position 342 of the mature protein. In CgA341, amino acids 339 and 341 were changed from glutamic acid and aspartic acid to glutamine and glutamic acid, respectively, during DNA manipulation. The mutagenesis primer for CgA387 (5Ј-GCGCGGCTAGCCGGATCCGAAGAAGGA-3Ј) added a stop codon at position 388. Both mutagenic primers also added a BamHI restriction endonuclease site for screening. The identity of the CgA mutants was confirmed by DNA sequencing. All clones were tested for expression by transient transfection of GH4C1 cells. Expression and secretion of CgA, CgA⌬CC, CgA341, and CgA387 were confirmed by immunoblotting of secretion media, while SEAP expression and secretion were confirmed by alkaline phosphatase activity.
Transient Expression of CgA in GH4C1 or PC12 Cells-Transfections of GH4C1 and PC12 cells were performed as described previously (11). The pcDNA3/CgA, pcDNA3/CgA⌬CC, pcDNA3/CgA341, pcDNA3/ CgA387, pcDNA3/SEAP plasmids (and pcDNA3 as a control) were used to transiently transfect GH4C1 or PC12 cells in separate experiments. Prior to secretion or fractionation experiments, the cells were treated with 5 mM sodium butyrate for 20 h.
For experiments using cycloheximide treatment, GH4C1 cells were hormone-treated as described (11). CgA and CgA341 were transiently expressed in hormone-treated GH4C1 cells. The cells were treated for 4 ϫ 30 min with 100 g/ml cycloheximide prior to secretion experiments. Stimulated and unstimulated secretion media were then collected for 30 min in the presence of cycloheximide. Secretion was stimulated in 1 ml of KRH buffer supplemented with 50 mM KCl, 100 nM phorbol 12-myristate 13-acetate, and 1 M Bay K8644. Unstimulated cells received 50 mM NaCl and 100 nM 4␣-phorbol 12,13-didecanoate.
Secretion of CgA, CgA341, and SEAP transiently expressed in PC12 cells was measured for 30 min in either 1 ml of KRH (unstimulated) or in low salt KRH (NaCl reduced to 79 mM, no CaCl 2 ) supplemented with 50 mM KCl and 2 mM BaCl 2 (stimulated).
For GH4C1 and PC12 cells, the secretion media were collected and centrifuged at 16,000 ϫ g for 5 min at 4°C to remove cell debris. The supernatants were transferred to new tubes, and Tween 20 and PMSF were added to final concentrations of 0.3% and 1 mM, respectively. EDTA was added to the GH4C1 medium to a concentration of 5 mM. The media containing secreted CgA and CgA mutants were heated at 100°C for 10 min and centrifuged to remove denatured proteins. Soluble proteins in the supernatant were trichloroacetic acid-precipitated and analyzed by immunoblotting.
To quantitate SEAP secretion, aliquots of secretion medium were diluted in KRH (1:50 for GH4C1 cells or 1:10 for PC12 cells) and alkaline phosphatase activity was determined with the Phospha-Light alkaline phosphatase assay kit and quantitated using a Berthold LB 9501 luminometer (Wallac, Inc., Gaithersburg, MD).
Pulse-Chase Experiments-Transiently transfected GH4C1 cells in six well plates were pulse-labeled (2 h, 37°C) with 50 Ci/well L- [4, H]leucine (specific activity 154 Ci/mMol) in 1 ml/well KRH. Following the 2-h pulse, cells were washed briefly with 1 ml of KRH containing 2 mM leucine and then chased for seven consecutive 30-min intervals at 37°C in 1 ml of KRH containing 2 mM leucine. The medium was replaced with fresh medium after each 30-min interval. Following the collection of basal secretion media for 3.5 h, the cells were incubated for 30 min in 1 ml of KRH containing 2 mM leucine, 50 mM KCl, 100 nM phorbol 12-myristate 13-acetate, and 1 M Bay K8644 and secretion medium was collected. The secretagogue mix was used to ensure optimal stimulated secretion of stored proteins (24). Immediately after each 30-min chase, secretion media samples were collected and centrifuged at 16,000 ϫ g for 2 min at 4°C and the supernatants were transferred to new microcentrifuge tubes and frozen until immunoprecipitated. CgA immunoreactivity was immunoprecipitated in 0.1 M sodium phosphate buffer (pH 7.4) using CgA antibody that had been bound to protein A-Sepharose. Only a negligible amount of CgA was not immunoprecipitated by this procedure, as revealed by a second immunoprecipitation of the supernatant fractions.
Separation of Soluble and Membrane Fractions-GH4C1 cells transiently transfected as described above were scraped from the plates into 1 ml of KRH containing 1 mM PMSF, 1 mM N ␣ -tosyl-L-lysine chloromethyl ketone, and 5 mM EDTA. The cells from duplicate wells were combined and lysed by scraping and repeated passage through a 26gauge hypodermic needle. Each sample was transferred to a 1.5-ml microcentrifuge tube, frozen, and thawed twice followed by centrifugation at 200 ϫ g for 5 min at 4°C. The supernatant was collected and centrifuged again at 16,000 ϫ g for 30 min at 4°C. The resulting pellet was resuspended in 50 l of the above buffer with or without 1% Triton X-100 and recentrifuged. After this centrifugation, the supernatant (soluble fraction) was transferred to a new tube and the pellet remaining was washed with 100 l of KRH containing the protease inhibitors and recentrifuged. After washing, the pellet (membrane fraction) and the soluble fraction from above were analyzed by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and immunoblotting.
Sucrose Gradient Separation-Transiently transfected GH4C1 cells from duplicate 35-mm culture wells were lysed, as described above, in 750 l of ice cold 0.3 M sucrose, 20 mM Hepes (pH 7.4). The cell lysate was centrifuged at 500 ϫ g for 5 min, and the supernatant fraction was layered on top of 750 l of ice-cold 0.6 M sucrose, 20 mM Hepes (pH 7.4) and centrifuged at 16,000 ϫ g for 30 min at 4°C. The 0.3 M and 0.6 M sucrose fractions and the pellet were adjusted to 1 ml total volume and 0.3% Tween 20. Total protein was precipitated with trichloroacetic acid in 0.3-0.45 M sucrose and analyzed by immunoblotting.
In Vitro Aggregation Experiment-The aggregation experiments were performed as described previously (11). Secretion medium containing SEAP was centrifuged, but not heated, before use.
Data Analysis-The quantitation of immunoblots was performed as described (11). -Fold stimulation was calculated as immunoreactive CgA in secretion medium from stimulated cells/immunoreactive CgA in secretion medium from unstimulated cells. -Fold stimulation was calculated for each individual experiment, and the mean Ϯ S.E. was determined from two to eight experiments. The data were analyzed by Student's t test, or an ordinary analysis of variance with Student-Neuman-Keuls test; p Ͻ 0.05 was considered statistically significant.

RESULTS
Chromogranins are highly conserved in both their N-and C-terminal regions. The N-terminal region is involved in sorting in PC12 cells but not in GH4C1 cells (11). To determine what regions of CgA were necessary for sorting in GH4C1 cells, we prepared three CgA mutants: CgA⌬CC (missing the conserved disulfide bond), CgA387 (missing the conserved C-terminal peptide that is involved in dimerization and tetramerization), and CgA341 (lacking the putative aggregation domain) (Fig. 1). These proteins were expressed in endocrine GH4C1 cells.
Pulse-chase experiments were used to test the sorting of wild-type CgA and the three CgA mutants in GH4C1 cells. The cells were pulse-labeled for 2 h, after which chase media were collected every 30 min until the addition of secretagogues to stimulate granule release at 3.5 h of chase (Fig. 2). Wild-type CgA, CgA⌬CC, and CgA387 each exhibited basal secretion that decreased over the first 2 h of chase incubation, consistent with the release of some non-stored CgA. Upon the addition of secretagogues, secretion of these three forms of CgA was strongly stimulated, consistent with granule storage (Fig. 2, compare the 3.5-h and 4.0-h time points). In contrast, the CgA341 deletion mutant was completely secreted without stimulation and did not exhibit stimulated secretion (Fig. 2). These results suggested that CgA341 was secreted only constitutively in GH4C1 cells. Therefore, the secretion and subcellular localization of this mutant were further analyzed.
The secretion of total, immunoreactive wild-type CgA and CgA341 were compared in hormone treated cells (Fig. 3). Hormone treatment stimulates prolactin granule formation in GH4C1 cells (27,28). We used the protein synthesis inhibitor cycloheximide to create a block of basal protein secretion (23,29). Under these conditions only proteins that were stored in secretory granules prior to cycloheximide treatment would be available for stimulated secretion (23,29). Indeed, secretion of wild-type CgA was stimulated 4.7-fold whereas secretion of CgA341 was only stimulated 2.0-fold under these conditions (Fig. 3). These findings suggested that, unlike wild-type CgA, which was sorted to the regulated secretory pathway, CgA341 was preferentially secreted by the constitutive or constitutivelike secretory pathway in GH4C1 cells.
Regulated secretory proteins are stored in dense core secretory granules, while constitutive secretory proteins are located in lighter Golgi and transport vesicles. To determine if wildtype CgA and CgA341 are located in different membrane compartments, a membrane pellet was prepared from transiently transfected GH4C1 cells. The membrane pellet was resuspended to gently disrupt the membrane, and the extent of CgA release was determined by immunoblotting. Wild-type CgA was efficiently retained in the membrane fraction (less than 20% released), while CgA341 was readily released from the membrane fraction (75% released) (Fig. 4). The differential release of the two forms of CgA suggested that they are located in different membrane compartments. The near complete extraction of both forms of CgA with the addition of Triton X-100 showed that the proteins are enclosed in a membrane compartment, as opposed to forming an insoluble aggregate (Fig. 4). CgA⌬CC and CgA387 were released similarly to wild-type CgA (not shown), consistent with their co-localization in secretory granules with wild-type CgA.
To further examine the subcellular localization of these proteins, a 0.3 and 0.6 M sucrose step gradient was used. Postnuclear supernatants were prepared in 0.3 M sucrose and then centrifuged on a 0.6 M sucrose cushion. The migration of CgA from 0.3 to 0.6 M sucrose was determined as an indicator of granule localization. Fig. 5 shows that only 10% of CgA341 migrated to the denser sucrose solution, whereas 30% of wild-type CgA was located in this fraction. This distribution suggests that CgA341 is stored less efficiently in dense core secretory granules than wild-type CgA. The pellets that were collected following the sucrose gradient centrifugation contained 30% of both forms of CgA (data not shown).
Regulated secretory proteins aggregate under the conditions of millimolar calcium concentrations and acidic pH that are found in the trans-Golgi network and secretory granules (e.g. Ref. 30), and this aggregation has repeatedly been suggested to play a role in sorting of regulated secretory proteins. Interestingly, aggregation is neither necessary nor sufficient for sorting in PC12 cells (12,16). To test if the missorting of CgA341 in GH4C1 cells could be explained by a lack of aggregation, the sorting and aggregation of wild-type CgA, CgA341, and the constitutive secretory pathway marker SEAP (28) were separately determined by immunoblotting (CgA) or alkaline phosphatase activity (SEAP). Fig. 6 shows that the sorting efficiency of wild-type CgA, CgA341, and SEAP is correlated with the aggregation efficiency of these proteins.
The results reported so far demonstrate that, although GH4C1 cells require a C-terminal domain for sorting of CgA (this report), PC12 cells use an N-terminal sorting domain in chromogranin (11)(12)(13)(14). To complete these data, we tested the sorting of CgA341 in PC12 cells. Sorting was assayed by immunoblotting of secretion medium collected in the presence or absence of secretagogues. Secretion of wild-type CgA and CgA341 were stimulated 47-and 65-fold, respectively. In con-  ϭ 8 -22). CgA341 and SEAP are different from wild-type (p Ͻ 0.05), but are not different from each other. In separate experiments, media samples were used for aggregation experiments. Percentage of aggregation ϭ (protein in pellet/protein in pellet ϩ protein in supernatant) ϫ 100%. Net aggregation (filled bars) ϭ % aggregation in the presence of calcium Ϫ % aggregation in the absence of calcium. CgA and SEAP aggregation data from three independent experiments are shown as mean Ϯ S.E. (n ϭ 6). CgA341 and SEAP are different from wild-type (p Ͻ 0.001), but are not different from each other. The data for wild-type include previously reported data that are shown for comparison (11). trast, the secretion of the constitutive secretory pathway marker SEAP was only stimulated 1.1-fold (Fig. 7). Thus, sorting of CgA341 was similar to that of wild-type CgA in these cells. The very high -fold stimulated secretions reported for wild-type CgA and CgA341 reflect the higher sorting efficiency of PC12 cells as compared with GH4C1 cells (11) and are due to the near absence of unstimulated secretion, as detected by Western blotting (Fig. 7A). Endogenous CgA is only present in low amounts in these cells and was not detected by immunoblotting (Fig. 7A, CTRL). DISCUSSION Chromogranin A contains two independent cell type-specific sorting signals: a conserved N-terminal disulfide bond, which was recently found to act as a sorting signal in neuroendocrine PC12 cells (11)(12)(13)(14), and a C-terminal sorting domain that is necessary for sorting in endocrine GH4C1 cells (this report). Importantly, the C-terminal domain is not necessary for sorting in PC12 cells (this report; Ref. 31), while the N-terminal domain is not necessary for sorting in GH4C1 cells (this report; Ref. 11). Thus, the two sorting signals complement each other to allow sorting of CgA to the regulated secretory pathway in both endocrine and neuroendocrine cells. It was recently proposed that sorting-for-entry dominates in neuroendocrine cells while sorting-by-retention dominates in endocrine cells (4). Our current data now provide a molecular mechanism for this proposed sorting difference.
The newly identified C-terminal sorting domain in CgA is necessary for calcium-induced condensation/aggregation of the protein. As used here, this includes local condensation of secretory proteins that is not necessarily receptor-mediated. Thus, this is the first evidence that calcium-induced aggregation plays a role in sorting of chromogranins. Such a mechanism had long been proposed to play a role in sorting or storage of chromogranins in secretory granules (6), but recent evidence from PC12 cells actually suggested that aggregation was neither necessary nor sufficient for sorting to the regulated secretory pathway (12,16). Calcium-induced aggregation, however, appears to play a role in sorting in some other cell types. Pro-atrial natriuretic factor contains two amino acids (Glu-23 and Glu-24) that are both necessary for sorting and calciuminduced aggregation in AtT-20 cells (17). In ␤-cells, pro-insulin is sorted to immature secretory granules but retention of the hormone in mature granules is enhanced after conversion of non-aggregating proinsulin to aggregating insulin (32). Together with the present data, these reports suggest that aggregation plays a cell-specific role in sorting and retention of regulated secretory proteins.
Comparison of the sorting of total CgA and newly synthesized CgA suggests that CgA341 partially enters secretory granules (2-2.8-fold stimulation of total protein; see Figs. 3 and 6) but that this protein is not stored in mature granules (no stimulated secretion after 3.5-h chase period, Fig. 2). Instead, CgA341 appears to be secreted by the constitutive-like secretory pathway. This is consistent with the poor aggregation of CgA341 since aggregation is thought to play a role in sortingby-retention in maturing secretory granules in endocrine cells (1,3,4,6).
CgA contains two dimerization domains that have been proposed to play a role in sorting to the regulated secretory pathway: an N-terminal dimerization domain that includes the disulfide bond (19) and a C-terminal dimerization/tetramerization domain (20,21). The data for CgA⌬CC and CgA387 now show that loss of either dimerization domain does not prevent sorting of CgA to secretory granules in GH4C1 cells (Fig. 2). Additionally, the C-terminal dimerization domain is not necessary for sorting of CgA in PC12 cells (Fig. 7). We cannot formally exclude that some of the CgA341 is sorted by forming heterotypic N-terminally linked dimers with endogenous CgA (13,19). However, the very low expression levels of endogenous CgA (see control lanes of Fig. 7A) makes this an unlikely explanation for the bulk sorting of overexpressed CgA341 in PC12 cells. Thus, the physiological function of these dimerization domains remains unclear.
The N-terminal domain of CgA has been proposed to play a role in binding to granule membranes, but it is not clear how.
We have previously noted that the N-terminal sorting domains of several regulated secretory proteins share similar secondary structures characterized by a hydrophobic domain that overlaps with an amphipathic ␣-helix (18). While it has been proposed that this structure interacts directly with lipid domains in the granule membrane (10), recent data suggest that this domain is not necessary for membrane binding of CgA in epithelial cells. 2 As an alternative to direct membrane binding, CgA may bind to membrane-associated proteins. It has recently been shown that POMC binds to membrane-bound carboxypeptidase E (9). POMC exhibits an N-terminal hydrophobic domain similar to the one found in CgA (18). In addition, this domain of POMC contains a disulfide bond that is necessary for sorting of POMC and binding to carboxypeptidase E (9). While it is clear that CgA does not bind to carboxypeptidase E (11,33), CgA may bind to other receptor-like proteins that are included in granule membranes.
The physiological significance of two independent sorting signals in CgA is not clear. It is possible that this is an adaptation to the widespread expression of chromogranins in most endocrine and neuroendocrine cells. Thus, the protein is equipped to enter secretory granules in cells that may exhibit different sorting mechanisms (4). It is of interest that, in a comparison of CgA sequences ranging from frog to man, the Nand C-terminal domains are the most highly conserved (34). An alternative, but not mutually exclusive, model is that the presence of multiple sorting signals is related to the physiological functions of CgA. The protein is a precursor for several biologically active peptides that play a role in the regulation of 2 U. Kü hn and S.-U. Gorr, unpublished results. A, immunoblotting of secretion medium from cells incubated in the absence (Ϫ) or presence (ϩ) of secretagogues. B, immunoblots from four to seven independent experiments were quantitated by densitometric scanning. The data in each experiment were normalized by dividing all values by the mean of the unstimulated samples, (unstimulated secretion ϭ 1, data not shown for clarity). The data are shown as mean Ϯ S.E. (n ϭ 11-16). Due to the low absorbance of the unstimulated samples, the background was not subtracted. The data for SEAP were confirmed by alkaline phosphatase assay (data not shown). endocrine secretion. These peptides are located in the N-terminal region, central region, and the C-terminal region of CgA (35). The presence of multiple sorting signals may ensure that N-and C-terminal fragments of CgA are correctly sorted after cell type-specific proteolytic processing of CgA. As an example, processing of CgA by furin is thought to produce parastatin and CgA347 (35). This shortened form of CgA is similar to the CgA341 tested in this report. Since furin processing takes place in the trans-Golgi network, the processed protein would contain the N-terminal but not the C-terminal sorting domain. Thus, this processing could determine the further routing and processing of CgA in the secretory pathway in different cell types. This proposed mechanism is similar to the processing of egg-laying hormones in neurons of Aplysia and Lymnaea. In these cells, cleavage by furin or furin-like enzymes determines the intracellular localization of the processing products in individual cell types (36,37). However, unlike sorting of egglaying hormones, which are sorted to different subcellular locations in individual cell types, the two sorting signals in CgA are used to reach equivalent secretory granules in different cell types.